Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001971:Bromocriptine / Q000494:pharmacology; D004088:Dihydroergotoxine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D004873:Ergolines / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000502:physiology
D001679:Biogenic Amines; D004873:Ergolines; D009570:Nitriles; D011725:Pyridines; D011955:Receptors, Drug; D004088:Dihydroergotoxine; D012701:Serotonin; D001971:Bromocriptine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D004298:Dopamine; D008784:Methysergide